Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 15705786)

Published in Blood on February 10, 2005

Authors

Pål Aukrust1, Luisa Luna, Thor Ueland, Rune F Johansen, Fredrik Müller, Stig S Frøland, Erling C Seeberg, Magnar Bjørås

Author Affiliations

1: Section of Clinical Immunology and Infectious Diseases, Research Institute for Internal Medicine, Oslo, Norway. pal.aukrust@rikshospitalet.no <pal.aukrust@rikshospitalet.no>

Articles by these authors

Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature (2003) 5.49

AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli. Nature (2002) 4.62

Adipose tissue distribution in relation to insulin sensitivity and inflammation in Pakistani and Norwegian subjects with type 2 diabetes. Scand J Clin Lab Invest (2014) 2.63

Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT (2003) 2.41

Human ABH3 structure and key residues for oxidative demethylation to reverse DNA/RNA damage. EMBO J (2006) 2.27

AlkB restores the biological function of mRNA and tRNA inactivated by chemical methylation. Mol Cell (2004) 2.26

Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. Blood (2010) 2.15

Up-regulation of NOTCH4 gene expression in bipolar disorder. Am J Psychiatry (2012) 2.04

Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation (2007) 2.00

Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab (2007) 1.99

Human DNA glycosylases of the bacterial Fpg/MutM superfamily: an alternative pathway for the repair of 8-oxoguanine and other oxidation products in DNA. Nucleic Acids Res (2002) 1.96

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Eur Heart J (2012) 1.93

Base excision repair. Cold Spring Harb Perspect Biol (2013) 1.91

C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. Eur Heart J (2009) 1.79

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord (2009) 1.74

Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J (2009) 1.71

Cerebral outcome in adult patients treated with extracorporeal membrane oxygenation. Ann Thorac Surg (2006) 1.68

Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study). Am J Cardiol (2006) 1.63

New functions of XPC in the protection of human skin cells from oxidative damage. EMBO J (2006) 1.60

Cytokine networks are pre-activated in T cells from HIV-infected patients on HAART and are under the control of cAMP. AIDS (2004) 1.54

Substrate specificities of bacterial and human AlkB proteins. Nucleic Acids Res (2004) 1.54

Effect of perfusion temperature on the inflammatory response during pediatric cardiac surgery. Ann Thorac Surg (2008) 1.52

Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Arterioscler Thromb Vasc Biol (2006) 1.47

Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial. Transplantation (2011) 1.46

Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes. J Am Coll Cardiol (2008) 1.45

Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke. Stroke (2011) 1.44

Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly. J Clin Endocrinol Metab (2012) 1.44

Effect of high-intensity interval training on progression of cardiac allograft vasculopathy. J Heart Lung Transplant (2013) 1.43

Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation. Cancer Res (2009) 1.40

[Should patients with severe sepsis be treated with activated protein C?]. Tidsskr Nor Laegeforen (2004) 1.39

[Risk of infection through use of selective immunomodulating drugs for rheumatoid arthritis]. Tidsskr Nor Laegeforen (2012) 1.39

Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure. Circulation (2005) 1.38

Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation (2002) 1.32

Systemic inflammation in heart failure--the whys and wherefores. Heart Fail Rev (2006) 1.30

Role of inflammation in the progression of heart failure. Curr Cardiol Rep (2007) 1.30

Incision at hypoxanthine residues in DNA by a mammalian homologue of the Escherichia coli antimutator enzyme endonuclease V. Nucleic Acids Res (2003) 1.29

Genomic sequence correction by single-stranded DNA oligonucleotides: role of DNA synthesis and chemical modifications of the oligonucleotide ends. J Gene Med (2005) 1.29

WRN interacts physically and functionally with the recombination mediator protein RAD52. J Biol Chem (2003) 1.27

Structures of endonuclease V with DNA reveal initiation of deaminated adenine repair. Nat Struct Mol Biol (2009) 1.26

Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications. Ann Med (2005) 1.25

Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I. J Immunol (2003) 1.25

Inflammatory cytokines in heart failure: mediators and markers. Cardiology (2012) 1.23

Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol (2008) 1.22

Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol (2006) 1.21

Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor. Nat Commun (2012) 1.19

Reciprocal "flipping" underlies substrate recognition and catalytic activation by the human 8-oxo-guanine DNA glycosylase. J Mol Biol (2002) 1.18

Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension (2002) 1.17

Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail (2013) 1.16

Characterization of the chitinolytic machinery of Enterococcus faecalis V583 and high-resolution structure of its oxidative CBM33 enzyme. J Mol Biol (2011) 1.16

Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue. Brain Behav Immun (2009) 1.15

DNA base repair--recognition and initiation of catalysis. FEMS Microbiol Rev (2009) 1.14

Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets. J Immunol (2006) 1.14

Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose. Eur J Endocrinol (2009) 1.13

Galectin-3 in heart failure: high levels are associated with all-cause mortality. Int J Cardiol (2011) 1.11

Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin Infect Dis (2004) 1.11

A new protein superfamily includes two novel 3-methyladenine DNA glycosylases from Bacillus cereus, AlkC and AlkD. Mol Microbiol (2006) 1.11

Human OGG1 undergoes serine phosphorylation and associates with the nuclear matrix and mitotic chromatin in vivo. Nucleic Acids Res (2002) 1.10

Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res (2003) 1.10

[Re: Hearing loss in children in Östfold county 2000-09]. Tidsskr Nor Laegeforen (2015) 1.08

Widespread distribution of DNA glycosylases removing oxidative DNA lesions in human and rodent brains. DNA Repair (Amst) (2008) 1.07

Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors. Circulation (2004) 1.07

Elevated levels of activin A in heart failure: potential role in myocardial remodeling. Circulation (2004) 1.07

A potential role of the CXC chemokine GROalpha in atherosclerosis and plaque destabilization: downregulatory effects of statins. Arterioscler Thromb Vasc Biol (2008) 1.06

Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials. Eur J Heart Fail (2012) 1.06

Structural insight into repair of alkylated DNA by a new superfamily of DNA glycosylases comprising HEAT-like repeats. Nucleic Acids Res (2007) 1.06

Dissection of the molecular defects caused by pathogenic mutations in the DNA repair factor XPC. Mol Cell Biol (2008) 1.06

Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV/AIDS. Qual Life Res (2005) 1.05

Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease. J Am Coll Cardiol (2003) 1.04

Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania. AIDS Res Ther (2008) 1.04

Endonuclease VIII-like 3 (Neil3) DNA glycosylase promotes neurogenesis induced by hypoxia-ischemia. Proc Natl Acad Sci U S A (2011) 1.04

The outer membrane secretin PilQ from Neisseria meningitidis binds DNA. Microbiology (2007) 1.04

Neutrophil gelatinase-associated lipocalin: a biomarker in COPD. Chest (2010) 1.03

Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44). J Mol Biol (2008) 1.02

Mitochondrial DNA damage level determines neural stem cell differentiation fate. J Neurosci (2011) 1.02

N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. Am J Cardiol (2006) 1.01

Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. J Lipid Res (2004) 1.00

A general role of the DNA glycosylase Nth1 in the abasic sites cleavage step of base excision repair in Schizosaccharomyces pombe. Nucleic Acids Res (2004) 1.00

Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy. AIDS (2009) 1.00

Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. J Psychiatr Res (2011) 1.00

Expression patterns of Neil3 during embryonic brain development and neoplasia. BMC Neurosci (2009) 0.99

Adiposity-related inflammation: effects of pregnancy. Obesity (Silver Spring) (2013) 0.99